Document Detail


Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit.
MedLine Citation:
PMID:  19786782     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To determine rates of fetal anaemia and pregnancy outcome in susceptible pregnant women infected with human parvovirus B19 infection in a tertiary fetal medicine department over a 7-year period. Additional features enabling identification of fetuses that progress to severe anaemia were also investigated. METHODS: Forty-seven susceptible, pregnant women with confirmed parvovirus infection referred to a regional fetal medicine unit, over a 7-year period (1999-2006), were identified. Where possible maternal serum AFP measurements were obtained from second-trimester serum screening and the presence or absence of echogenic bowel noted. RESULTS: Of the 47 cases, one was excluded. Of the remaining 46 cases, 34 (74%) showed no signs of fetal anaemia and delivered at term. The remaining 12 (26%) showed signs of fetal anaemia. Eight of the 12 developed hydrops and underwent fetal blood sampling and transfusion (median pretransfusion Hb 3.6 g/dl). Seven of the 8 transfused fetuses were thrombocytopenic with a platelet count <150 x 10(9)/l, with 2 fetuses having platelet counts <50 x 10(9)/l. The median gestation age at transfusion was 22 weeks (range 18-27 weeks). The median number of weeks between seroconversion and transfusion was 6 (range 3-12). The signs of anaemia resolved after one transfusion in 5 of the 8 transfused fetuses and they subsequently delivered at term. There were 2 fetal deaths during or shortly after transfusion and one neonatal death following delivery at 28 weeks gestation due to severe pre-eclampsia, 5 days after successful transfusion. CONCLUSIONS: Following parvovirus seroconversion, the incidence of significant fetal anaemia requiring transfusion was 17%. Seroconversion after 21 weeks did not result in severe fetal anaemia. Significant anaemia requiring intervention did not occur 12 weeks after maternal seroconversion. We did not demonstrate a correlation with either maternal serum AFP or the presence of fetal echogenic bowel and the development of severe fetal anaemia. Because of the association between fetal anaemia and severe thrombocytopenia, it may be prudent to have compatible platelets available at the time of fetal blood sampling.
Authors:
R A Simms; R E Liebling; R R Patel; M L Denbow; S A Abdel-Fattah; P W Soothill; T G Overton
Publication Detail:
Type:  Journal Article     Date:  2009-09-30
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  25     ISSN:  1421-9964     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:  2009  
Date Detail:
Created Date:  2009-09-29     Completed Date:  2009-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  373-8     Citation Subset:  IM    
Copyright Information:
2009 S. Karger AG, Basel
Affiliation:
Regional Fetal Medicine Research Group, Fetal Medicine Unit, St. Michael's Hospital, Bristol, UK. becky.simms@doctors.org.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia / diagnosis,  embryology,  therapy*,  virology
Biological Markers / blood
Blood Transfusion, Intrauterine*
Female
Fetal Death
Gestational Age
Humans
Hydrops Fetalis / therapy,  virology
Infant, Newborn
Intestines / embryology,  ultrasonography
Middle Cerebral Artery / embryology,  ultrasonography
Parvoviridae Infections / diagnosis,  embryology,  therapy*,  virology
Parvovirus B19, Human / pathogenicity*
Pregnancy
Pregnancy Complications, Infectious / virology*
Pregnancy Outcome
Retrospective Studies
Severity of Illness Index
Thrombocytopenia / diagnosis,  embryology,  therapy*,  virology
Treatment Outcome
Ultrasonography, Doppler
Ultrasonography, Prenatal
alpha-Fetoproteins / metabolism
Chemical
Reg. No./Substance:
0/AFP protein, human; 0/Biological Markers; 0/alpha-Fetoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Three- and four-dimensional fetal echocardiography.
Next Document:  Fetal transfusion of red blood cells for alloimmunization: validity of a published equation.